肛管癌腹股沟CTV勾画:Garda指南的比较验证与共识启示
本研究回顾性分析2015–2024年接受IMRT的肛管鳞癌(ASCC)伴影像学阳性腹股沟淋巴结患者,基于Garda指南勾画腹股沟CTV并评估其对203枚淋巴结的覆盖效果。Garda CTV覆盖90%淋巴结,11%淋巴结未被覆盖,多位于上外侧区,提示指南有效但需进一步优化以完善靶区勾画共识。
要点
- Garda指南CTV覆盖90%腹股沟淋巴结,主要遗漏上外侧区(7%)。
- 88%淋巴结位于股血管前内侧,无淋巴结位于后方。
- 30%患者存在至少一枚淋巴结未被CTV覆盖,需个体化调整。
核心结论
- Garda指南可有效减少后外侧象限不必要的照射,但存在覆盖缺口,需进一步优化腹股沟CTV勾画。
研究设计与样本
- 回顾性分析2015–2024年单中心接受IMRT的ASCC伴影像学阳性腹股沟淋巴结患者,基于Garda指南勾画ILNs并进行描述性分析。
主要发现
- 46例患者中27例(59%)为cT3-T4期,27例(59%)为双侧腹股沟淋巴结受累。
- 共分析203枚ILNs,88%(178枚)位于股血管前内侧。
- Garda CTV覆盖182枚(90%),22枚(11%)未被覆盖,涉及14例患者(30%)。
- 未覆盖淋巴结多位于上外侧区(15枚,占全部7%),6枚(3%)位于下区,仅1枚位于上内侧象限,无淋巴结位于后方。
关键数值与推荐
- Garda指南CTV覆盖182/203枚(90%)ILNs,未覆盖22枚(11%)。
临床怎么用
- 临床可参考Garda指南勾画腹股沟CTV,但需关注上外侧区和下区可能遗漏的淋巴结,个体化调整靶区。
局限性
- 回顾性单中心研究,样本量有限,未报告其他验证队列或长期结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Contouring Inguinal lymph nodes (ILNs) in anal squamous cell cancer (ASCC) remains challenging. Accurate delineation is essential to optimize treatment efficacy with sparing of organs at risk (OaRs). Garda et al. proposed a contouring guideline based on the anatomical distribution of inguinal lymphadenopathy. This study evaluates their effectiveness in ensuring adequate ILNs coverage. MATERIALS AND METHODS: We retrospectively analyzed ASCC patients with radiologically positive inguinal lymph nodes treated with IMRT in our institution between 2015 and 2024. ILNs were mapped relative to the femoral vessels and delineated based on the Garda's guidelines. Descriptive analyses were conducted. RESULTS: Among 46 patients with positive ILNs, 27 (59%) had cT3-T4 stage and 27 (59%) had bilateral inguinal nodal involvement. Overall, 203 ILNs were analyzed: 88% (178 nodes) were anteromedial to the femoral vessels. Garda's CTV encompassed 182 nodes (90%), while 22 nodes (11%) across 14 patients (30%) were not covered. Most of the uncovered nodes were in the superolateral region (n = 15, 7% of all nodes), whereas 6 nodes (3%) from six patients were identified in the inferior region. Only one node was found in the superomedial quadrant, while no nodes were located posteriorly. CONCLUSIONS: These findings validate the proposed guidelines, confirming their effectiveness in reducing unnecessary irradiation of the posterolateral quadrant. However, coverage gaps highlight the need for further refinements to optimize target delineation. These findings offer disease-specific evidence to inform the harmonization of inguinal CTV delineation and support the development of standardized, consensus-based contouring protocols.
引用
- De Luca V, Manfrida S, Barogi N, et al. Inguinal CTV contouring in anal cancer: comparative validation of inguinal lymph nodes contouring guidelines and implications for consensus. Clin Transl Radiat Oncol. 2026. PMID: 41756143. doi:10.1016/j.ctro.2026.101130
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。